Search Results - "van Walree, Nico"

An Unexpected Finding of an Aggressive Pleural Hemangiopericytoma/Solitary Fibrous Tumor in a Patient With Recurrent Meningioma: A Case Report by Basir, Shahir, Bosiers, Jana, van Walree, Nico C

“…Pleural hemangiopericytoma/solitary fibrous tumor (HPC/SFT) is a rare form of mesenchymal tumor arising from pericytes, which predominantly occurs…”
Get full text

Clinical Outcomes of Patients With Metastatic NSCLC After Discontinuation of Immunotherapy Because of Immune-Related Adverse Effects by Lievense, Lysanne A., Heukels, Peter, van Walree, Nico C., van der Leest, Cor H.

“…Immune checkpoint inhibition (ICI) is an important treatment modality in metastatic NSCLC and management of immunotherapy-related adverse effects (irAEs) can…”
Get full text

The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study by de Mol, Mark, Visser, Sabine, Aerts, Joachim, Lodder, Paul, van Walree, Nico, Belderbos, Huub, den Oudsten, Brenda

“…Identification of patient-related factors associated with Health-Related Quality of Life (HRQoL) and Quality of Life (QoL) at the start of treatment may…”
Get full text

Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer by Visser, Sabine, Koolen, Stijn, van Donk, Nadine, van Walree, Nico, van der Leest, Cor, Cornelissen, Robin, van Schaik, Ron, Mathijssen, Ron, Aerts, Joachim, Stricker, Bruno H

“…Patients with advanced non-small-cell lung cancer who are treated with pemetrexed display a wide variation in clinical response and toxicity. In this…”
Get more information

Renal impairment during pemetrexed maintenance in patients with advanced nonsmall cell lung cancer: a cohort study by Visser, Sabine, Huisbrink, Jeannine, van 't Veer, Nils E, van Toor, Jermo J, van Boxem, Anton J M, van Walree, Nico C, Stricker, Bruno H, Aerts, Joachim G J V

“…Optimal survival benefit from different lines of anticancer treatment in advanced nonsmall cell lung cancer (NSCLC) requires conservation of renal function. We…”
Get full text

Frequency of low-grade adverse events and quality of life during chemotherapy determine patients’ judgement about treatment in advanced-stage thoracic cancer by de Mol, Mark, Visser, Sabine, den Oudsten, Brenda L., Lodder, Paul, van Walree, Nico, Belderbos, Huub, Aerts, Joachim G.

“…Purpose In lung cancer, the preservation of well-being is warranted given the limited prognosis. Chemotherapy may negatively influence health-related quality…”
Get full text

High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study by Dingemans, Anne-Marie, van Walree, Nico, Schramel, Franz, Soud, Magdolen Youssef-El, Baltruškevičienė, Edita, Lybaert, Willem, Veldhorst, Margriet, van den Berg, Claudia A, Kaasa, Stein

“…ESPEN guidelines recommend a minimum protein intake of 1.0 g/kg body weight (BW) per day to maintain or restore lean body mass in patients with cancer. During…”
Get full text

Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma by Steendam, Christi M.J., Peric, Robert, van Walree, Nico C., Youssef, Magdolen, Schramel, Franz M.N.H., Brocken, Pepijn, van Putten, John W.G., van der Noort, Vincent, Veerman, G.D. Marijn, Koolen, Stijn L.W., Groen, Harry J.M., Dingemans, Anne-Marie C., Mathijssen, Ron H.J., Smit, Egbert F., Aerts, Joachim G.J.V.

“…•Patients with relapsed NSQ-NSCLC were included in this phase III trial.•We compared docetaxel plus intercalated erlotinib to docetaxel monotherapy.•Docetaxel…”
Get full text

Treatment Satisfaction of Patients With Advanced Non–Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL) by Visser, Sabine, de Mol, Mark, Cheung, Kiki, van Toor, Jermo J., van Walree, Nico C., Stricker, Bruno H., Den Oudsten, Brenda L., Aerts, Joachim G.J.V.

“…To gain insight into the patient-centered value of treatment harms and benefits, we prospectively evaluated the satisfaction with therapy (SWT) in patients…”
Get full text

Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial by de Gooijer, Cornedine J, van der Noort, Vincent, Stigt, Jos A, Baas, Paul, Biesma, Bonne, Cornelissen, Robin, van Walree, Nico, van Heemst, Robbert C, Soud, Magdolen Youssef-El, Groen, Harry J M, den Brekel, Agnes J Staal-van, Buikhuisen, Wieneke A, Bootsma, Gerben P, Dammeijer, Floris, van Tinteren, Harm, Lalezari, Ferry, Aerts, Joachim G, Burgers, Jacobus A

“…Almost all patients with malignant mesothelioma eventually have disease progression after first-line therapy. Previous studies have investigated maintenance…”
Get full text

Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) by Belderbos, José, Uitterhoeve, Lon, van Zandwijk, Nico, Belderbos, Huub, Rodrigus, Patrick, van de Vaart, Paul, Price, Allan, van Walree, Nico, Legrand, Catherine, Dussenne, Sonia, Bartelink, Harry, Giaccone, Giuseppe, Koning, Caro

“…Abstract A randomised phase III study was performed comparing sequential (S) and concurrent (C) chemo-radiotherapy (CRT) in non-small cell lung cancer (NSCLC)…”
Get full text

An Unexpected Finding of an Aggressive Pleural Hemangiopericytoma/Solitary Fibrous Tumor in a Patient With Recurrent Meningioma: A Case Report by Basir, Shahir, Bosiers, Jana, van Walree, Nico C

“…Pleural hemangiopericytoma/solitary fibrous tumor (HPC/SFT) is a rare form of mesenchymal tumor arising from pericytes, which predominantly occurs…”
Get full text